内嵌的应用

POST #1 – Exhibit 1

 

 

50% of patients who have died from COVID-19 had acquired a secondary bacterial infection.

Source: The Lancet

POST #1 – Exhibit 2

 

 

As of March 2020, 44 COVID-19 vaccines were in development; only five developers were MSCI ACWI Index constituents.

Source: World Health Organization, MSCI ESG Research LLC.

内嵌的应用

POST #1 – Exhibit 3

 

 

Only 9% of health care constituents of the MSCI ACWI IMI have acknowledged antimicrobial resistance as a public health risk.

Source: MSCI ESG Research, as of October 2019

 

POST #1 – Exhibit 4

 

 

Only 39 biopharma companies globally have antibiotics in the regulatory pipeline.

Source: MSCI ESG Research, as of October 2019.

 

POST #1 – Footnotes

©2020 MSCI Inc. All rights reserved

 

POST #1 – Next button

 Next   

post 2 related content